0
0

Medical Supply Chain Security Act

2/8/2022, 11:17 PM

Congressional Summary of HR 6049

Medical Supply Chain Security Act

This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage.

Current Status of Bill HR 6049

Bill HR 6049 is currently in the status of Bill Introduced since March 2, 2020. Bill HR 6049 was introduced during Congress 116 and was introduced to the House on March 2, 2020.  Bill HR 6049's most recent activity was Referred to the House Committee on Energy and Commerce. as of March 2, 2020

Bipartisan Support of Bill HR 6049

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
5
Democrat Cosponsors
1
Republican Cosponsors
4
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 6049

Primary Policy Focus

Health

Potential Impact Areas

- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Health information and medical records
- Health technology, devices, supplies
- Manufacturing
- Prescription drugs

Alternate Title(s) of Bill HR 6049

Medical Supply Chain Security Act
To amend the Federal Food, Drug, and Cosmetic Act to provide enhanced security for the medical supply chain.
Medical Supply Chain Security Act

Comments